116 related articles for article (PubMed ID: 37294554)
1. Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs.
Lu Z; Gao Z; Song H; Zhou Y; Yuan W; Wang X; Zhang L; Hong Y; Meng Y; Hu J; Zheng G; Chang C
Chem Biodivers; 2023 Jul; 20(7):e202300086. PubMed ID: 37294554
[TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
4. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
[TBL] [Abstract][Full Text] [Related]
5. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
6. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.
Al-Rabia MW; Alhakamy NA; Rizg WY; Alghaith AF; Ahmed OAA; Fahmy UA
Drug Deliv; 2022 Dec; 29(1):807-820. PubMed ID: 35266425
[TBL] [Abstract][Full Text] [Related]
7. Gemini Curcumin Suppresses Proliferation of Ovarian Cancer OVCAR-3 Cells via Induction of Apoptosis.
Ghaderi S; Babaei E; Hussen BM; Mahdavi M; Azeez HJ
Anticancer Agents Med Chem; 2021; 21(6):775-781. PubMed ID: 32767955
[TBL] [Abstract][Full Text] [Related]
8. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib.
Feriotto G; Marchetti P; Rondanin R; Tagliati F; Aguzzi S; Beninati S; Casciano F; Tabolacci C; Mischiati C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768681
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin.
Reddy CA; Somepalli V; Golakoti T; Kanugula AK; Karnewar S; Rajendiran K; Vasagiri N; Prabhakar S; Kuppusamy P; Kotamraju S; Kutala VK
PLoS One; 2014; 9(3):e89351. PubMed ID: 24622734
[TBL] [Abstract][Full Text] [Related]
11. Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation.
Mohammed F; Rashid-Doubell F; Taha S; Cassidy S; Fredericks S
Int J Oncol; 2020 Aug; 57(2):445-455. PubMed ID: 32626932
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and
Wang J; Liu Q; Yang L; Xia X; Zhu R; Chen S; Wang M; Cheng L; Wu X; Wang S
J Biomed Nanotechnol; 2017 Dec; 13(12):1631-1646. PubMed ID: 29490752
[TBL] [Abstract][Full Text] [Related]
13. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
Wei X; Senanayake TH; Bohling A; Vinogradov SV
Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
15. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
[TBL] [Abstract][Full Text] [Related]
18. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
19. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
20. Curcuminoids Induce Reactive Oxygen Species and Autophagy to Enhance Apoptosis in Human Oral Cancer Cells.
Hsiao YT; Kuo CL; Chueh FS; Liu KC; Bau DT; Chung JG
Am J Chin Med; 2018; 46(5):1145-1168. PubMed ID: 29976081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
